Literature DB >> 31207467

Lifespan normative data on rates of brain volume changes.

Marco Battaglini1, Giordano Gentile1, Ludovico Luchetti1, Antonio Giorgio1, Hugo Vrenken2, Frederik Barkhof3, Keith S Cover4, Rohit Bakshi5, Renxin Chu5, Maria Pia Sormani6, Christian Enzinger7, Stefan Ropele8, Olga Ciccarelli9, Claudia Wheeler-Kingshott10, Marios Yiannakas11, Massimo Filippi12, Maria Assunta Rocca12, Paolo Preziosa12, Antonio Gallo13, Alvino Bisecco13, Jacqueline Palace14, Yazhuo Kong15, Dana Horakova16, Manuela Vaneckova17, Claudio Gasperini18, Serena Ruggieri18, Nicola De Stefano19.   

Abstract

We provide here normative values of yearly percentage brain volume change (PBVC/y) as obtained with Structural Imaging Evaluation, using Normalization, of Atrophy, a widely used open-source software, developing a PBVC/y calculator for assessing the deviation from the expected PBVC/y in patients with neurological disorders. We assessed multicenter (34 centers, 11 acquisition protocols) magnetic resonance imaging data of 720 healthy participants covering the whole adult lifespan (16-90 years). Data of 421 participants with a follow-up > 6 months were used to obtain the normative values for PBVC/y and data of 392 participants with a follow-up <1 month were selected to assess the intrasubject variability of the brain volume measurement. A mixed model evaluated PBVC/y dependence on age, sex, and magnetic resonance imaging parameters (scan vendor and magnetic field strength). PBVC/y was associated with age (p < 0.001), with 60- to 70-year-old participants showing twice more volume decrease than participants aged 30-40 years. PBVC/y was also associated with magnetic field strength, with higher decreases when measured by 1.5T than 3T scanners (p < 0.001). The variability of PBVC/y normative percentiles was narrower as the interscan interval was longer (e.g., 80th normative percentile was 50% smaller for participants with 2-year than with 1-year follow-up). The use of these normative data, eased by the freely available calculator, might help in better discriminating pathological from physiological conditions in the clinical setting.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Aging; Atrophy; Brain volume; MRI; Normative data

Mesh:

Year:  2019        PMID: 31207467     DOI: 10.1016/j.neurobiolaging.2019.05.010

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  13 in total

1.  Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability.

Authors:  Marinos G Sotiropoulos; Hrishikesh Lokhande; Brian C Healy; Mariann Polgar-Turcsanyi; Bonnie I Glanz; Rohit Bakshi; Howard L Weiner; Tanuja Chitnis
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-05-28

Review 2.  Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.

Authors:  Dániel Sandi; Zsanett Fricska-Nagy; Krisztina Bencsik; László Vécsei
Journal:  Molecules       Date:  2021-06-05       Impact factor: 4.411

3.  Whole Brain and Cranial Size Adjustments in Volumetric Brain Analyses of Sex- and Age-Related Trends.

Authors:  Marek Kijonka; Damian Borys; Krzysztof Psiuk-Maksymowicz; Kamil Gorczewski; Piotr Wojcieszek; Bartosz Kossowski; Artur Marchewka; Andrzej Swierniak; Maria Sokol; Barbara Bobek-Billewicz
Journal:  Front Neurosci       Date:  2020-04-03       Impact factor: 4.677

4.  Age-dependent cut-offs for pathological deep gray matter and thalamic volume loss using Jacobian integration.

Authors:  Roland Opfer; Julia Krüger; Lothar Spies; Marco Hamann; Carla A Wicki; Hagen H Kitzler; Carola Gocke; Diego Silva; Sven Schippling
Journal:  Neuroimage Clin       Date:  2020-10-27       Impact factor: 4.881

5.  Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis.

Authors:  Tomas Uher; Jan Krasensky; Charles Malpas; Niels Bergsland; Michael G Dwyer; Eva Kubala Havrdova; Manuela Vaneckova; Dana Horakova; Robert Zivadinov; Tomas Kalincik
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-03-16

6.  Contralesional Structural Plasticity in Different Molecular Pathologic Subtypes of Insular Glioma.

Authors:  Zhenxing Huang; Gen Li; Zhenye Li; Shengjun Sun; Yazhuo Zhang; Zonggang Hou; Jian Xie
Journal:  Front Neurol       Date:  2021-04-14       Impact factor: 4.003

7.  LesionQuant for Assessment of MRI in Multiple Sclerosis-A Promising Supplement to the Visual Scan Inspection.

Authors:  Synne Brune; Einar A Høgestøl; Vanja Cengija; Pål Berg-Hansen; Piotr Sowa; Gro O Nygaard; Hanne F Harbo; Mona K Beyer
Journal:  Front Neurol       Date:  2020-12-11       Impact factor: 4.003

8.  Early Brain Volume Changes After Stroke: Subgroup Analysis From the AXIS-2 Trial.

Authors:  Ning Bu; Leonid Churilov; Mohamed Salah Khlif; Robin Lemmens; Anke Wouters; Jochen B Fiebach; Angel Chamorro; E Bernd Ringelstein; Bo Norrving; Rico Laage; Martin Grond; Guido Wilms; Amy Brodtmann; Vincent Thijs
Journal:  Front Neurol       Date:  2022-01-28       Impact factor: 4.003

9.  Progressive Multiple Sclerosis Is Associated with Faster and Specific Retinal Layer Atrophy.

Authors:  Elias S Sotirchos; Natalia Gonzalez Caldito; Angeliki Filippatou; Kathryn C Fitzgerald; Olwen C Murphy; Jeffrey Lambe; James Nguyen; Julia Button; Esther Ogbuokiri; Ciprian M Crainiceanu; Jerry L Prince; Peter A Calabresi; Shiv Saidha
Journal:  Ann Neurol       Date:  2020-04-28       Impact factor: 10.422

Review 10.  MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice.

Authors:  Jaume Sastre-Garriga; Deborah Pareto; Marco Battaglini; Maria A Rocca; Olga Ciccarelli; Christian Enzinger; Jens Wuerfel; Maria P Sormani; Frederik Barkhof; Tarek A Yousry; Nicola De Stefano; Mar Tintoré; Massimo Filippi; Claudio Gasperini; Ludwig Kappos; Jordi Río; Jette Frederiksen; Jackie Palace; Hugo Vrenken; Xavier Montalban; Àlex Rovira
Journal:  Nat Rev Neurol       Date:  2020-02-24       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.